Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
Year: 2026
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-00640
Authors: Dan-Yun Ruan, Feng-Hua Wang, Yujuan Zhou, Yanqun Xiang, Jinguan Lin, Lin Liu, Ping Liu, Linquan Tang, Yuxiang Ma, Tao Hou, Qiuyan Chen, Zhi-Ming Li, Fei Han, Song Qu, Sufang Qiu, Chen Han, Hongzhi Ma, Fang Su, Jin Gao, Ye Guo, Zheng Wu, Hai-Jun Wu, Yanqiu Zhao, Meiyu Fang, Man Hu, Yuan Wu, Shuo Cui, Mengyun Li, Qiong Zhao, Rui-Hua Xu
Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Hunan Cancer Hospital, Second Xiangya Hospital of Central South University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Fujian Provincial Cancer Hospital, University of Science and Technology of China, Tongji University, Shanghai East Hospital, Central South University, Xiangya Hospital Central South University, Zhengzhou University, Henan Cancer Hospital, Zhejiang Cancer Hospital, Shandong Tumor Hospital, Shandong First Medical University, Hubei Cancer Hospital
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204194126